2024-02-29
The IL-1 signaling pathway in bladder cancer
Oncology
In bladder carcinoma, there is an imbalance between IL-1 and the IL-1 receptor antagonist. This signaling pathway is therefore of interest for the development of new therapeutic strategies. In this study, we evaluated the expression profiles and prognostic role of IL-1-beta and IL-1 receptor antagonist (IL-1 RA) in invasive bladder carcinoma. The study was conducted on two independent cohorts of 92 and 102 patients who had undergone radical cystectomy. IL-1β and IL-1RA were significantly overexpressed in invasive versus benign urothelium in both cohorts. IL-1-beta protein expression was of prognostic significance in bladder cancer.

Last press reviews
MicroRNAs & Microbiota: An Inflammatory Duo?

#MicroRNA #Microbiota #IBD #Immunotherapy #Innov...
Vaccine-derived poliovirus: a threat under surveillance

#Poliovirus #InfectiousDiseases #Vaccine #Vaccination&...
HBsAg and immunity: a barrier or an ally against hepatitis B?

#InfectiousDiseases #Hepatitis #HepatitisB #Immunity